Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		5 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (7,713,000)	$ (8,018,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	271,000	330,000
Non-cash operating lease expense		42,000
Stock-based compensation	218,000	110,000
Provision for inventory impairment		82,000
Amortization of term loan discount		5,000
Impairment - Goodwill	0		$ 30,300,000
Impairment - Intangibles, net			18,900,000
Change in fair value of convertible notes payable	(190,000)	(1,673,000)
Change in fair value of warrant liabilities	(38,000)	80,000
Net change in operating assets and liabilities:
Accounts receivable, net	34,000	70,000
Inventory, net	256,000	(281,000)
Prepaid expenses and other current assets	63,000	90,000
Accounts payable	(193,000)	884,000
Accrued liabilities	(577,000)	678,000
Accrued transaction costs		199,000
Other accrued liabilities	658,000	706,000
Operating lease liabilities		(43,000)
Net cash used in operating activities	(7,211,000)	(6,739,000)
Cash flows from investing activities:
Purchases of property and equipment	(335,000)	(162,000)
Net cash used in investing activities	(335,000)	(162,000)
Cash flows from financing activities:
Proceeds from issuance of convertible notes payable		10,000,000
Repayment of non-convertible term loan		(429,000)
Net cash provided by financing activities		9,571,000
Effect of foreign currency translation on cash and cash equivalents	(77,000)	30,000
Net change in cash and cash equivalents	(7,623,000)	2,700,000
Cash and cash equivalents, at beginning of period	20,586,000	1,383,000
Cash and cash equivalents, at end of period	$ 12,963,000	4,083,000	$ 20,586,000
Supplemental disclosure of cash flow information:
Cash paid for interest		$ 43,000